Literature DB >> 9655489

Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate.

F D Batista1, M S Neuberger.   

Abstract

Initiation and affinity maturation of the humoral immune response is driven by antigen interaction with BCR. To study how signaling and antigen presentation through BCR depend on antigen/BCR affinity, lysozyme-specific B cell transfectants were challenged with mutated lysozymes differing in their binding kinetics. For detectable triggering, the antigen/BCR complex needed a Ka > 10(6) M(-1) (dissociation half-life > approximately 1 s). Mutated lysozymes whose binding was below this threshold could nevertheless be presented if complexed with soluble antibody. Above the threshold, the concentration of antigen required to trigger a response decreased as the affinity (particularly dissociation half-life) increased. However, a plateau was reached at Kas > approximately 10(10) M(-1) (dissociation half-life > 0.5 hr), supporting the idea of a ceiling to affinity maturation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655489     DOI: 10.1016/s1074-7613(00)80580-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  164 in total

Review 1.  Memory in the B-cell compartment: antibody affinity maturation.

Authors:  M S Neuberger; M R Ehrenstein; C Rada; J Sale; F D Batista; G Williams; C Milstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

2.  Regulation of VH gene repertoire and somatic mutation in germinal centre B cells by passively administered antibody.

Authors:  H Song; X Nie; S Basu; M Singh; J Cerny
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

3.  Kinetics of association of anti-lysozyme monoclonal antibody D44.1 and hen-egg lysozyme.

Authors:  G Altobelli; S Subramaniam
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

4.  Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.

Authors:  Barbara J Vilen; Kathy M Burke; Michelle Sleater; John C Cambier
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

5.  Breaking the affinity ceiling for antibodies and T cell receptors.

Authors:  J Foote; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity.

Authors:  E T Boder; K S Midelfort; K D Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation.

Authors:  Claire L Adams; Megan K L Macleod; E James Milner-White; Robert Aitken; Paul Garside; David I Stott
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

8.  MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Authors:  Surender Khurana; Nitin Verma; Jonathan W Yewdell; Anne Katrin Hilbert; Flora Castellino; Maria Lattanzi; Giuseppe Del Giudice; Rino Rappuoli; Hana Golding
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

Review 9.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

10.  Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.

Authors:  Paola Martinez-Murillo; Karen Tran; Javier Guenaga; Gustaf Lindgren; Monika Àdori; Yu Feng; Ganesh E Phad; Néstor Vázquez Bernat; Shridhar Bale; Jidnyasa Ingale; Viktoriya Dubrovskaya; Sijy O'Dell; Lotta Pramanik; Mats Spångberg; Martin Corcoran; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.